Company Search:
Advanced Search
Sponsored Links
Curis, Inc. Company Snapshot
Curis, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Curis with three other companies in this sector in the United States: Enzon Pharmaceuticals, Inc. (2018 sales of $6.92 million ), Acceleron Pharma Inc ($13.99 million of which 100% was Bio-pharmaceutical), and La Jolla Pharmaceutical Company ($10.06 million of which 100% was Pharmaceutical Products).

Sales Analysis. Curis reported sales of $10.43 million for the year ending December of 2018. This represents an increase of 5.4% versus 2017, when the company's sales were $9.90 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Curis, Inc.
  Stock Performance Chart for Curis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 2.01
(Figures in U.S. Dollars)
1 Week 10.4%   13 Weeks -12.6%  
4 Weeks 22.6%   52 Weeks 38.6%  
Curis, Inc. Key Data:
  Ticker: CRIS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 10,428,000
(Year Ending Jan 2019).
Employees: 31
  Currency: U.S. Dollars Market Cap: 66,737,771
  Fiscal Yr Ends: December Shares Outstanding: 33,202,871
  Share Type: COMMON Closely Held Shares: 5,682,159
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.